120
Participants
Start Date
May 31, 2008
Primary Completion Date
July 31, 2008
Study Completion Date
September 30, 2008
OC000459
"Tablets twice daily for 8 days~Dose level 1"
OC000459
"Tablets twice daily for 8 days~Dose level 2"
OC000459
"Tablets twice daily for 8 days~Dose level 3"
OC000459
"Tablets twice daily for 8 days~Dose level 4"
Placebo
"Tablets twice daily for 8 days~Dose level 5"
Allergie Zentrum Wien West, Vienna Challenge Chamber, Vienna
Lead Sponsor
Oxagen Ltd
INDUSTRY